Medilife Impex Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 03-07-2024
- Paid Up Capital ₹ 0.10 M
as on 03-07-2024
- Company Age 12 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 7.00 Cr
as on 03-07-2024
- Revenue -4.25%
(FY 2022)
- Profit -25.83%
(FY 2022)
- Ebitda -6.94%
(FY 2022)
- Net Worth 28.01%
(FY 2022)
- Total Assets 4.73%
(FY 2022)
About Medilife Impex
The Company is engaged in the E-Commerce Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company has closed loans amounting to ₹7.00 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Fidaequaem Varawalla and Fazle Chimthanawala serve as directors at the Company.
- CIN/LLPIN
U51101MH2012PTC228514
- Company No.
228514
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Mar 2012
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Hingna, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Medilife Impex Private Limited offer?
Medilife Impex Private Limited offers a wide range of products and services, including Homeopathic Drugs, Sugar Globules, Hand Sanitizers & Personal Hygiene, Hair Shampoo, Homoeopathic Drops, Toiletry Set, Guest Amenities, Hand Wash, Herbal Hand Wash, Common Disease Medicines.
Who are the key members and board of directors at Medilife Impex?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Fidaequaem Varawalla  | Director | 20-Mar-2012 | Current |
| Fazle Chimthanawala | Director | 07-Nov-2019 | Current |
Financial of Medilife Impex.
Medilife Impex Private Limited, for the financial year ended 2022, experienced Minor drop in revenue, with a 4.25% decrease. The company also saw a substantial fall in profitability, with a 25.83% decrease in profit. The company's net worth Soared by an impressive increase of 28.01%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Medilife Impex?
Unlock access to Medilife Impex's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Canara Bank Creation Date: 11 Jan 2016 | ₹3.00 Cr | Satisfied |
Canara Bank Creation Date: 17 Jan 2014 | ₹4.00 Cr | Satisfied |
How Many Employees Work at Medilife Impex?
Medilife Impex has a workforce of 32 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Medilife Impex, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medilife Impex's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
